Ken Griffin Walgreens Boots Alliance, Inc. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$8.26 - $12.16 $3.6 Million - $5.3 Million	436,100 Added 13.11%	3,761,900 $33.7 Million
Q2 2024 Aug 14, 2024	SELL	$12.1 - $19.54 $5.85 Million - $9.44 Million	-483,100 Reduced 12.68%	3,325,800 $40.2 Million
Q1 2024 May 15, 2024	BUY	$20.51 - $26.65 $24.3 Million - $31.5 Million	1,183,400 Added 45.07%	3,808,900 $82.6 Million
Q4 2023 Feb 14, 2024	BUY	$19.94 - $26.64 $14.5 Million - $19.4 Million	727,500 Added 38.33%	2,625,500 $68.6 Million
Q3 2023 Nov 14, 2023	SELL	$20.9 - $30.85 $2.4 Million - $3.54 Million	-114,700 Reduced 5.7%	1,898,000 $42.2 Million
Q2 2023 Aug 14, 2023	SELL	$28.37 - $36.31 $17.9 Million - $22.9 Million	-631,400 Reduced 23.88%	2,012,700 $57.3 Million
Q1 2023 May 15, 2023	BUY	$32.33 - $37.71 $22.3 Million - $26 Million	688,900 Added 35.23%	2,644,100 $91.4 Million
Q4 2022 Feb 14, 2023	SELL	$30.52 - $41.79 $2.92 Million - $4 Million	-95,600 Reduced 4.66%	1,955,200 $73 Million
Q3 2022 Nov 14, 2022	SELL	$31.4 - $42.04 $15.8 Million - $21.1 Million	-502,900 Reduced 19.69%	2,050,800 $64.4 Million

1,032

505M

24.4M

25.6M

Ticker WBA
Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Shares Outstandng 864,812,992
Market Cap $7.77B
Description
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.